Rchr
J-GLOBAL ID:202001000261342380
Update date: May. 29, 2024
Hinohara Kunihiko
ヒノハラ クニヒコ | Hinohara Kunihiko
Affiliation and department:
Job title:
Designated associate professor
Research field (2):
Molecular biology
, Tumor biology
Research keywords (10):
非コード領域
, 細胞進化軌跡
, がん細胞不均一性
, 細胞系譜追跡
, 細胞可塑性
, 細胞多様性
, tumor evolution
, synthetic lethality
, epigenetics
, tumor heterogeneity
Research theme for competitive and other funds (9):
- 2024 - 2027 CRISPRタイリングスクリーンを用いたがん分子標的の機能性ドメイン探索と機能解析
- 2023 - 2026 がん薬剤耐性化におけるパーシスター細胞の運命決定機構
- 2022 - 2025 がん免疫療法における耐性化機序と進化軌跡の解明
- 2020 - 2024 エピゲノムダイナミクスに基づくがん多様性の新たな理解
- 2020 - 2023 The evolutional trajection and precision-medicine to gliomas
- 2020 - 2023 Deciphering the mechanism of synthetic lethality in glioma
- 2020 - 2022 Identification of STING agonist transporter in cancer cells by utilizing a lineage barcoding system
- 2020 - 2022 Deciphering mechanisms of immune escape by single-cell barcoding
- 2019 - 2021 Mechanism for synthetic lethality in SWI/SNF-deficient breast cancers
Show all
Papers (20):
-
Komine, O, Ohnuma, S, Hinohara, K, Hara, Y, Shimada, M, Akashi, T, Watanabe, S, Sobue, A, Kawade, N, Ogi, T, et al. Genetic background variation impacts microglial heterogeneity and disease progression in amyotrophic lateral sclerosis model mice. ISCIENCE. 2024. 27. 2. 108872
-
Xiao, MR, Kondo, S, Nomura, M, Kato, S, Nishimura, K, Zang, WJ, Zhang, YF, Akashi, T, Viny, A, Shigehiro, T, et al. BRD9 determines the cell fate of hematopoietic stem cells by regulating chromatin state. NATURE COMMUNICATIONS. 2023. 14. 1. 8372
-
Sugiyama, D, Hinohara, K, Nishikawa, H. Significance of regulatory T cells in cancer immunology and immunotherapy. EXPERIMENTAL DERMATOLOGY. 2023. 32. 3. 256-263
-
Kato, S, Maeda, Y, Sugiyama, D, Watanabe, K, Nishikawa, H, Hinohara, K. The cancer epigenome: Non-cell autonomous player in tumor immunity. CANCER SCIENCE. 2023. 114. 3. 730-740
-
Tsujino, T, Takai, T, Hinohara, K, Gui, F, Tsutsumi, T, Bai, X, Miao, CK, Feng, C, Gui, B, Sztupinszki, Z, et al. CRISPR screens reveal genetic determinants of PARP inhibitor sensitivity and resistance in prostate cancer. NATURE COMMUNICATIONS. 2023. 14. 1. 252
more...
Education (2):
- 2006 - 2009 Tokyo Medical and Dental University Biomedical Science PhD Program
- - 2004 Tokyo University of Science Faculty of Science Department of Applied Chemistry
Professional career (1):
- Ph.D. (Tokyo Medical and Dental University)
Work history (7):
- 2019/07 - 現在 Nagoya University Department of Immunology, Graduate School of Medicine/Institute for Advanced Research Designated associate professor
- 2019/07 - 現在 Nagoya University Institute for Advanced Research Designated associate professor
- 2019/07/01 - 現在 Nagoya University Graduate School of Medicine Program in Integrated Medicine Microbiology and Immunology Designated associate professor
- 2014/04 - 2019/06 Dana-Farber Cancer Institute Medical Oncology Research fellow
- 2012/04 - 2014/03 The University of Tokyo Division of Molecular Therapy, Institute for Medical Science Designated assistant professor
- 2010/04 - 2012/03 The University of Tokyo Division of Systems Biomedical Technology, Institute for Medical Science, Designated assistant professor
- 2009/04 - 2010/03 The University of Tokyo Division of Systems Biomedical Technology, Institute for Medical Science, Post-doctoral fellow
Show all
Return to Previous Page